Abbassy, Mahmoud
Ali, Muhammad Zain
Sharma, Riya Manas
Irani, Yohan Porus
Dahlan, Adil
Azhar, Maimoona
Aslam, Nadeem
Hasan, Babar
Hameed, Aamir http://orcid.org/0000-0002-9242-6185
Funding for this research was provided by:
Royal College of Surgeons in Ireland
Article History
Accepted: 18 June 2024
First Online: 28 June 2024
Declarations
:
: Dr Aamir Hameed is a Co-Founder and Chief Medical Officer (CMO) of a Startup, an RCSI and Tissue Engineering Research Group (TERG) spinout, Pumpinheart Ltd., which is developing a novel miniaturised heart pump for Heart Failure with preserved Ejection Fraction (HFpEF). The rest of the authors do not have any known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.